Просмотр новости
Найдите то, что Вас интересует
Спутники
РН
SpaceX
Роскосмос
NASA
СпутникиРНSpaceXРоскосмосNASAThe higher-dosage GLP-1 agonists largely engendered greater cardiometabolic improvements.
| # | Наименование новости | Тональность | Информативность | Дата публикации |
|---|---|---|---|---|
| 1 | Most obesity drugs do not improve quality of life or heart health, analysis indicates | -2 | 7 | 08-07-2026 |
| 2 | GLP-1 'secret shopper' study finds gaps in online prescribing | 0 | 5 | 07-07-2026 |
| 3 | Women more often hired after losing weight on GLP-1s: Study | 0 | 5 | 03-07-2026 |
| 4 | GLP-1 use hits record high as Medicare opens access to weight-loss drugs | 0 | 7 | 09-07-2026 |
| 5 | After weight loss, exercise beats weight-loss drugs for heart health | 0 | 9.66 | 21-07-2026 |
| 6 | Hope for new low cost slimming pill as daily tablet beats oral semaglutide in trial | 0 | 7.86 | 26-02-2026 |
| 7 | Wegovy warning: Users of weight loss jab are five times more likely to suffer permanent sight loss, finds new study | 0 | 5.2 | 11-03-2026 |
| 8 | Most websites prescribe GLP-1s without clinician visit | 0 | 7 | 09-07-2026 |
| 9 | Statins and blood pressure drugs changing health risks of obesity, study suggests | 0 | 7 | 01-07-2026 |